Case reportPublished 2015
Prostatic Ductal Adenocarcinoma: Case Report and Literature Review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Prostatic Duct Adenocarcinoma (PDA), not a unique disease but with nearly 5% of the prostate carcinoma, clinically deviated from common Prostatic Acinar Adenocarcinoma (PAA) in recent years and was deemed the exact existence even with its long-standing origin debates. Addedly, it was usually more aggressive than PAA in most studies. As for our daily urologic practice, the 2 PDA cases (with obstruction symptoms; with gross hematuria) progressed to imaging-indicated bone metastases and were probably historically in the large primary periurethral prostatic ducts or the peripheral prostatic ducts and extending exophytically into the urethra and most commonly in and around the verumontanum before retrospective chart reviews. Convincingly, though the early diagnosis and aggressive treatment failed, long term follow-up for disease outcomes stayed serious. Indeed, the rate of the gene fusion in the pure PDA was significantly lower genetically and biologically than that in the PAA and will be likewise examined.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology-Open Access
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Sheng-Lung Hsu”
- BylineArticles whose byline prints “Chien-Feng Li”
- BylineArticles whose byline prints “Kun-Hung Shen”
- BylineArticles whose byline prints “Chiu-Lan Chen”
- BylineArticles whose byline prints “Mei-Li Chen”
